Insiders who reported open-market trades in the last 12 months at the companies Kevin Lobo files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Ronda E. Stryker - $580.89M in SYK purchases and sales in the last 12 months
Andrew D. Ross - $10.47M in PH purchases and sales in the last 12 months
Berend Bracht - $6.91M in PH purchases and sales in the last 12 months
Dinu J. Parel - $5.98M in PH purchases and sales in the last 12 months
Mark J. Hart - $5.47M in PH purchases and sales in the last 12 months
Kevin Lobo is a corporate insider, tracked as Director of GE HealthCare Technologies Inc. (GEHC). InsiderAlpha holds 11 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Kevin Lobo last file a Form 4?
The most recent primary Form 4 on record is dated 26 May 2026, one of 11 filings going back to 2024.
Has Kevin Lobo been buying or selling stock?
Recorded transactions: 1 open-market purchase ($642K) and 3 open-market sales ($21.13M) across all tracked filings.
Kevin Lobo is Director of GE HealthCare Technologies Inc. (GEHC). 11 SEC Form 4 filings on record going back to 2024, most recently on 26 May 2026. Most recent open-market trade: bought $642K of GEHC on 26 May 2026. Lifetime open-market purchases: $642K. Lifetime open-market sales: $21.13M.
Recent transactions
17
The latest 17 SEC Form 4 transactions reported by Kevin Lobo.
InsiderAlpha's records for Kevin Lobo go back to 2024: 11 primary Form 4 filings, an average of 3.7 per year. The typical open-market purchase is $642K (1 buy totaling $642K). The largest single buy on record is $642K of GEHC in 2026. Sales side: 3 recorded sales totaling $21.13M, so the filing history runs sell-heavy by dollar value. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
